Deerfield Management’s Windtree Therapeutics WINT Stock Holding History

Deerfield Management’s Portfolio WINT Stock Details WINT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-676	Closed	-$215K	–	575
2024 Q1	$215K	Buy	+676	New	+$258K	﹤0.01%	320
2022 Q4	–	Hold	0	–	-$6K	–	125
2022 Q3	–	Hold	0	–	–	–	127
2022 Q2	–	Hold	0	–	–	–	124
2022 Q1	–	Hold	0	–	–	–	118
2021 Q4	–	Hold	0	–	–	–	127
2021 Q3	–	Hold	0	–	–	–	133
2021 Q2	–	Hold	0	–	–	–	143
2021 Q1	–	Hold	0	–	–	–	133
2020 Q4	–	Hold	0	–	–	–	129
2020 Q3	–	Hold	0	–	–	–	105
2020 Q2	–	Hold	0	–	–	–	93

Other funds holding WINT

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AWM

Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Deerfield Management's WINT Position: Q2 2024 in Review

Deerfield Management sold out of Windtree Therapeutics (WINT) in Q2 2024, closing a stake of 676 shares — an estimated $215K sold.

Deerfield Management first reported a position in WINT in Q1 2024 and held it in 1 quarter. The position peaked at $215K in Q1 2024. 1 fund tracked by Wall St. Rank holds WINT as of Q2 2024.

Deerfield Management reported no remaining Windtree Therapeutics position as of Q2 2024 after selling out during the quarter.
Deerfield Management sold 676 Windtree Therapeutics shares in Q2 2024, an estimated $215K.
Deerfield Management first reported a position in Windtree Therapeutics in Q1 2024 and held it in 1 quarter.
Deerfield Management's Windtree Therapeutics position peaked at $215K in Q1 2024.
1 fund tracked by Wall St. Rank held Windtree Therapeutics as of Q2 2024.

Based on Deerfield Management's 13F filing for Q2 2024, filed 14 Aug 2024.